Galera Therapeutics, Inc.

Transforming the science and treatment of cancer

Add To Watchlist
General Information
Company Name
Galera Therapeutics, Inc.
Founded Year
2009
Location (Offices)
Malvern, United States +2
Founders / Decision Makers
Jennifer Evans Stacey - Chief Legal and Compliance Officer (CLCO) & Secretary Sorensen Mel - President & CEO Dennis P. Riley - Co-Founder & Chief Scientific Officer Jon T. Holmlund - Chief Medical Officer Robert Beardsley - Founder & Chief Operating Officer Mark J. Bachleda - Chief Commercial Officer Colleen A. Hamilton - Vice President Human Resources
Number of Employees
15
Industries
Biotechnology, Health and Wellness, Life Sciences
Funding Stage
Post Ipo Equity
Social Media

Galera Therapeutics, Inc. - Company Profile

Galera Therapeutics, Inc. is a biotechnology startup founded in 2009 and headquartered in the United States. The company's slogan, "Transforming the science and treatment of cancer," reflects its focus on developing and commercializing a pipeline of novel, proprietary therapeutics that aim to revolutionize radiotherapy in cancer. The company recently secured a significant $30.00M Post-IPO Equity investment on 15 February 2023.

Taxonomy: cancer treatment, radiotherapy, therapeutics, proprietary drugs, oncology, pharmaceuticals, novel treatments, clinical trials, cancer research

Funding Rounds & Investors of Galera Therapeutics, Inc. (12)

View All
Funding Stage Amount No. Investors Investors Date
Post-IPO Equity $30.00M - 15 Feb 2023
Venture Round Unknown 1
Frazier Healthcare Partners, investor in Galera Therapeutics, Inc.'s Venture Round round
01 Jan 2020
Series C $70.00M 10
New Enterprise Associates, investor in Galera Therapeutics, Inc.'s Series C round Correlation Ventures, investor in Galera Therapeutics, Inc.'s Series C round HBM Healthcare Investments, investor in Galera Therapeutics, Inc.'s Series C round Novartis Venture Fund, investor in Galera Therapeutics, Inc.'s Series C round Sofinnova Investments, investor in Galera Therapeutics, Inc.'s Series C round Nan Fung Life Sciences, investor in Galera Therapeutics, Inc.'s Series C round Rock Springs Capital, investor in Galera Therapeutics, Inc.'s Series C round
Tekla Capital Management, Novo Ventures +1 		19 Sep 2018
Series B $15.00M 1
Sofinnova Investments, investor in Galera Therapeutics, Inc.'s Series B round
28 Nov 2016
Series B $5.00M 7
New Enterprise Associates, investor in Galera Therapeutics, Inc.'s Series B round Correlation Ventures, investor in Galera Therapeutics, Inc.'s Series B round Novartis Venture Fund, investor in Galera Therapeutics, Inc.'s Series B round St. Louis Arch Angels, investor in Galera Therapeutics, Inc.'s Series B round Enso Ventures, investor in Galera Therapeutics, Inc.'s Series B round
Novo Ventures, Galera Angels 		03 Feb 2016

View All 12 Funding Rounds

Latest News of Galera Therapeutics, Inc.

View All

No recent news or press coverage available for Galera Therapeutics, Inc..

Similar Companies to Galera Therapeutics, Inc.

View All
Leap Therapeutics - Similar company to Galera Therapeutics, Inc.
Leap Therapeutics
Gladius Therapeutics - Similar company to Galera Therapeutics, Inc.
Gladius Therapeutics Developing groundbreaking therapies to disrupt mitochondrial function in cancer cells.
G1 Therapeutics, Inc. - Similar company to Galera Therapeutics, Inc.
G1 Therapeutics, Inc. Our mission is to discover, develop and deliver next generation cancer therapies.
PIC Therapeutics - Similar company to Galera Therapeutics, Inc.
PIC Therapeutics Modulating Oncogene Translation to Dramatically Improve Cancer Patient Outcomes
Sustainable Cell Therapeutics - Similar company to Galera Therapeutics, Inc.
Sustainable Cell Therapeutics Pioneering cancer immunotherapy with a focus on patient rehabilitation and treatment of resilient and recurring cancers
Circle Decoration Circle Decoration

Want to dive deeper into Galera Therapeutics, Inc.? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now